Boston Partners
ELAN icon

Boston Partners’s Elanco Animal Health ELAN Stock Holding History

Boston Partners’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-259,826
Closed -$5.57M – 651
2020
Q2 		$5.57M Sell
259,826
-18,403
-7% -$406K 0.01% 357
2020
Q1 		$6.21M Buy
+278,229
New +$7.62M 0.01% 361

Other funds holding ELAN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Boston Partners's ELAN Position: Q3 2020 in Review

Boston Partners sold out of Elanco Animal Health (ELAN) in Q3 2020, closing a stake of 259,826 shares — an estimated $5.57M sold.

Boston Partners first reported a position in ELAN in Q1 2020 and held it in 2 quarters. The position peaked at $6.21M in Q1 2020. 361 funds tracked by Wall St. Rank hold ELAN as of Q3 2020.

  • Boston Partners reported no remaining Elanco Animal Health position as of Q3 2020 after selling out during the quarter.
  • Boston Partners sold 259,826 Elanco Animal Health shares in Q3 2020, an estimated $5.57M.
  • Boston Partners first reported a position in Elanco Animal Health in Q1 2020 and held it in 2 quarters.
  • Boston Partners's Elanco Animal Health position peaked at $6.21M in Q1 2020.
  • 361 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2020.

Based on Boston Partners's 13F filing for Q3 2020, filed 9 Nov 2020.